Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Daridorexant crossover study in Japanese patients with insomnia disorder
jRCT2080224596Phase 2Completed
- Sponsor
- Idorsia
- Start
- Mar 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of daridorexant in Insomnia (4 arms), sponsored by Idorsia. Started Mar 2019; status: completed.
02
Drugs
daridorexant
03
Conditions
Insomnia
Beyond the preview
Go deeper on jRCT2080224596.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080224596.